VSEs for Vaccines

VSE™s for Vaccines are upstream viral production enhancers designed to improve vaccine yields and support scalable manufacturing. Proven across human and animal health applications, VSEs have increased viral yields by 2-6x across multiple cell lines, virus types, and cell-based and egg-based production platforms, helping accelerate timelines, reduce costs, and improve process consistency. Read More

Want to learn more? Contact an Expert

Product Overview
Supporting Data

Product Overview

Higher yields, faster paths to target titers
Boosts viral yields 2-6x to help reach target titers sooner, shorten manufacturing timelines, and keep vaccine programs on track.
Compatible Across Vaccine Production Systems
Proven across human and animal health vaccine workflows, with compatibility across multiple cell lines, virus types, and both cell-based and egg-based production platforms.
Drop in upstream enhancer
A simple media additive that integrates into existing workflows and supports scalable vaccine production.

Supporting Data

Addition of VSE™ during Vero-cell based production of various strains of Influenza showed enhancements in titer between 1.8-5.6 fold.

Addition of VSE™ in ovo demonstrates 6-fold enhancement of Influenza (H1N1) infectious titer (n=6 independent experiments), with no significant impact on embryo weight.